Press Releases Year All202320222021 12/28/21 Kiniksa Announces Results from Phase 3 Trial of Mavrilimumab in COVID-19-Related ARDS 11/23/21 Kiniksa Pharmaceuticals to Present at Evercore ISI 4th Annual HealthCONx Conference 11/01/21 Kiniksa Pharmaceuticals Reports Third Quarter 2021 Financial Results and Recent Portfolio Execution 10/29/21 Kiniksa Pharmaceuticals to Report Third Quarter 2021 Financial Results on November 1, 2021 09/21/21 Kiniksa Pharmaceuticals to Present at 2021 Cantor Fitzgerald Virtual Global Healthcare Conference 08/16/21 Kiniksa Announces Launch of ARCALYST Named Patient Program 08/03/21 Kiniksa Reports Second Quarter 2021 Financial Results and Recent Corporate and Portfolio Activity 08/02/21 Kiniksa Pharmaceuticals to Present at 2021 Wedbush PacGrow Healthcare Conference 07/20/21 Kiniksa Pharmaceuticals to Report Second Quarter 2021 Financial Results on August 3, 2021 06/08/21 Kiniksa Announces Issuance of U.S. Patent for Treatment of Recurrent Pericarditis 06/08/21 Kiniksa Outlines Next Steps for the Development of Mavrilimumab 06/01/21 Kiniksa Pharmaceuticals to Present at Goldman Sachs 42nd Annual Global Healthcare Conference 05/04/21 Kiniksa Reports First Quarter 2021 Financial Results and Recent Corporate and Portfolio Activity 05/04/21 Kiniksa Announces Positive Final Data from Phase 1 Trial of KPL-404 04/12/21 Kiniksa Announces Positive Results for Mavrilimumab Phase 2 Trial in Non-Mechanically Ventilated Severe COVID-19 Patients 04/01/21 Kiniksa Announces Commercial Availability of ARCALYST ® (rilonacept) for Recurrent Pericarditis 03/18/21 Kiniksa Announces FDA Approval of ARCALYST ® (rilonacept) for Recurrent Pericarditis 03/02/21 Kiniksa Launches Patient Registry (RESONANCE) for Recurrent Pericarditis 02/23/21 Kiniksa Reports Fourth Quarter and Full-Year 2020 Financial Results and Corporate and Pipeline Activity 01/11/21 Kiniksa Highlights Corporate Priorities and Expected 2021 Milestones 01/04/21 Kiniksa Pharmaceuticals to Present at 39th Annual J.P. Morgan Healthcare Conference Print Page RSS Email Alerts Search
Year All202320222021 12/28/21 Kiniksa Announces Results from Phase 3 Trial of Mavrilimumab in COVID-19-Related ARDS 11/23/21 Kiniksa Pharmaceuticals to Present at Evercore ISI 4th Annual HealthCONx Conference 11/01/21 Kiniksa Pharmaceuticals Reports Third Quarter 2021 Financial Results and Recent Portfolio Execution 10/29/21 Kiniksa Pharmaceuticals to Report Third Quarter 2021 Financial Results on November 1, 2021 09/21/21 Kiniksa Pharmaceuticals to Present at 2021 Cantor Fitzgerald Virtual Global Healthcare Conference 08/16/21 Kiniksa Announces Launch of ARCALYST Named Patient Program 08/03/21 Kiniksa Reports Second Quarter 2021 Financial Results and Recent Corporate and Portfolio Activity 08/02/21 Kiniksa Pharmaceuticals to Present at 2021 Wedbush PacGrow Healthcare Conference 07/20/21 Kiniksa Pharmaceuticals to Report Second Quarter 2021 Financial Results on August 3, 2021 06/08/21 Kiniksa Announces Issuance of U.S. Patent for Treatment of Recurrent Pericarditis 06/08/21 Kiniksa Outlines Next Steps for the Development of Mavrilimumab 06/01/21 Kiniksa Pharmaceuticals to Present at Goldman Sachs 42nd Annual Global Healthcare Conference 05/04/21 Kiniksa Reports First Quarter 2021 Financial Results and Recent Corporate and Portfolio Activity 05/04/21 Kiniksa Announces Positive Final Data from Phase 1 Trial of KPL-404 04/12/21 Kiniksa Announces Positive Results for Mavrilimumab Phase 2 Trial in Non-Mechanically Ventilated Severe COVID-19 Patients 04/01/21 Kiniksa Announces Commercial Availability of ARCALYST ® (rilonacept) for Recurrent Pericarditis 03/18/21 Kiniksa Announces FDA Approval of ARCALYST ® (rilonacept) for Recurrent Pericarditis 03/02/21 Kiniksa Launches Patient Registry (RESONANCE) for Recurrent Pericarditis 02/23/21 Kiniksa Reports Fourth Quarter and Full-Year 2020 Financial Results and Corporate and Pipeline Activity 01/11/21 Kiniksa Highlights Corporate Priorities and Expected 2021 Milestones 01/04/21 Kiniksa Pharmaceuticals to Present at 39th Annual J.P. Morgan Healthcare Conference